ARCHITECT I2000SR ANALYZER 3M74-95

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01 report with the FDA on 2009-09-21 for ARCHITECT I2000SR ANALYZER 3M74-95 manufactured by Abbott Manufacturing, Inc..

Event Text Entries

[1149122] The customer states that patient samples processed using the architect cmv igm assay are generating falsely positive results. The customer states that results are negative when samples are sent out of the lab for confirmation testing. No specific patient data was provided. No adverse outcomes were reported related to this issue.
Patient Sequence No: 1, Text Type: D, B5


[8314393] (b) (4) this is an initial report. An investigation is in process. A final report will be submitted when the investigation is complete.
Patient Sequence No: 1, Text Type: N, H10


[8406182] (b)(4). Other (b)(4): erratic cytomegalovirus (cmv) igg, (b)(6), and rubella igg results. Investigation plan summary: a review of the complaint text indicates the customer observed rubella igg and (b)(6) controls failing. The customer is also experiencing low reactive cytomegalovirus (cmv) igg patient results that are retested negative when sent for confirmation. Even after replacing the sample probe, the issue persisted. The customer also noticed excessive crystal build up around the sample probe wash cup, which continuously returned after cleaning the area. The field service engineer (fse) installed technical service bulletin (tsb) (b)(4) architect software v5. 10 installation onto the analyzer on (b)(6) 2009. He replaced and calibrated the reagent 1, reagent 2, and sample probes. The fse removed the syringes to check and clean all the pipettor and tubing connections. No leaks were observed in the pump bay area. He tightened all of the wash zone, pretrigger, trigger valves. The wash zone 1 and 2 aspiration, optics background, trigger, and pretrigger gravimetric tests were performed. All these tests passed specifications. The quality control values were within acceptable ranges. No sample carryover issues were observed during the carryover study. The precision of rubella igg, (b)(6), and cmv igm were within normal ranges. Review of complaint metrics identified no adverse trends in conjunction with the complaint issue currently under evaluation. Based on the available information, no deficiency identified for this complaint. A malfunction of the system was not identified. After the field service engineer performed a multipoint instrument check and troubleshooting of the instrument, the customer issue has not reoccurred, the instrument has been performing as intended. This is the final report.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1628664-2009-00443
MDR Report Key1477076
Report Source01
Date Received2009-09-21
Date of Report2009-09-11
Date of Event2009-09-11
Date Mfgr Received2009-10-20
Device Manufacturer Date2006-01-17
Date Added to Maude2010-02-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI KONDOS RN, BSN
Manufacturer Street200 ABBOTT PARK ROAD DEPT. 09B9, AP50
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone8479375120
Manufacturer G1ABBOTT MANUFACTURING, INC.
Manufacturer Street1921 HURD DRIVE
Manufacturer CityIRVING TX 75038
Manufacturer CountryUS
Manufacturer Postal Code75038
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARCHITECT I2000SR ANALYZER
Generic NameAUTOMATED IMMUNOASSAY ANALYZER
Product CodeOMI
Date Received2009-09-21
Catalog Number3M74-95
OperatorOTHER
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABBOTT MANUFACTURING, INC.
Manufacturer Address1921 HURD DRIVE IRVING TX 75038 US 75038


Patients

Patient NumberTreatmentOutcomeDate
10 2009-09-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.